# Pre-ESRD Syndrome in High Risk African Americans

> **NCT00224939** · NA · TERMINATED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 144 (estimated)

## Conditions studied

- Blood Pressure

## Interventions

- **DRUG:** Potassium Chloride

## Key facts

- **NCT ID:** NCT00224939
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 144 (ESTIMATED)
- **Why stopped:** Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show primary endpoint
- **Last updated:** 2010-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224939, "Pre-ESRD Syndrome in High Risk African Americans". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00224939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*